Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CBA Florida, Inc. stock logo
CBAI
CBA Florida
$0.01
+1.3%
$0.01
$0.01
$0.01
$9.91MN/A2.73 million shs19.77 million shs
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
$0.19
$0.26
$2.11
$17.50
$792K2.722.44 million shs19,116 shs
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
$0.00
$0.01
$0.00
$0.01
$140K0.8810,128 shsN/A
OpGen, Inc. stock logo
OPGN
OpGen
$4.73
$4.83
$0.53
$5.25
$47.62M-1.689,280 shs88 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CBA Florida, Inc. stock logo
CBAI
CBA Florida
0.00%0.00%0.00%0.00%0.00%
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
0.00%0.00%0.00%0.00%0.00%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
0.00%0.00%-33.96%-28.77%-43.24%
OpGen, Inc. stock logo
OPGN
OpGen
0.00%+0.64%+5.11%+18.25%+80.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CBA Florida, Inc. stock logo
CBAI
CBA Florida
N/AN/AN/AN/AN/AN/AN/AN/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
N/AN/AN/AN/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CBA Florida, Inc. stock logo
CBAI
CBA Florida
0.00
N/AN/AN/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
0.00
N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
0.00
N/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CBA Florida, Inc. stock logo
CBAI
CBA Florida
N/AN/AN/AN/AN/AN/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
$6.33M0.13N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
$30K4.61N/AN/A($0.99) per share0.00
OpGen, Inc. stock logo
OPGN
OpGen
$2.67M17.82N/AN/A($11.55) per share-0.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CBA Florida, Inc. stock logo
CBAI
CBA Florida
-$40KN/A0.00N/AN/AN/AN/AN/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
N/A-$2.07N/AN/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
-$3.85M-$0.13N/AN/AN/AN/A-96.09%N/A
OpGen, Inc. stock logo
OPGN
OpGen
-$32.67MN/A0.00N/A-1,140.36%N/A-287.58%7/7/2025 (Estimated)

Latest CGIX, OPGN, CBAI, and FCHS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/A-$0.04N/A-$0.04N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CBA Florida, Inc. stock logo
CBAI
CBA Florida
N/AN/AN/AN/AN/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
N/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CBA Florida, Inc. stock logo
CBAI
CBA Florida
N/AN/AN/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/A
5.45
5.45

Institutional Ownership

CompanyInstitutional Ownership
CBA Florida, Inc. stock logo
CBAI
CBA Florida
N/A
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
8.92%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/A
OpGen, Inc. stock logo
OPGN
OpGen
2.68%

Insider Ownership

CompanyInsider Ownership
CBA Florida, Inc. stock logo
CBAI
CBA Florida
30.00%
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
15.00%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
30.81%
OpGen, Inc. stock logo
OPGN
OpGen
43.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
CBA Florida, Inc. stock logo
CBAI
CBA Florida
21.27 billion890.45 millionNot Optionable
Cancer Genetics Inc. stock logo
CGIX
Cancer Genetics
N/A4.09 millionN/ANot Optionable
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
20732.96 million22.80 millionNot Optionable
OpGen, Inc. stock logo
OPGN
OpGen
10010.07 million4.70 millionNot Optionable

Recent News About These Companies

OpGen Forms Joint Venture with European Bank
OpGen Appoints New COO and Company Secretary
OPGN Stock Earnings: OpGen Reported Results for Q2 2024
OPGN Stock Earnings: OpGen Meets Revenue for Q4 2023
OpGen, Inc.: OpGen Announced 1-for-10 Reverse Stock Split
OpGen Announced 1-for-10 Reverse Stock Split

Media Sentiment Over Time

CBA Florida stock logo

CBA Florida OTCMKTS:CBAI

$0.0078 +0.00 (+1.30%)
As of 06/30/2020

CBA Florida, Inc. does not have significant operations. Previously, the company provided private cord blood and cord tissue stem cell services. The company was formerly known as Cord Blood America, Inc. and changed its name to CBA Florida, Inc. in May 2018. CBA Florida, Inc. is based in Las Vegas, Nevada.

Cancer Genetics stock logo

Cancer Genetics NASDAQ:CGIX

Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Its programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders, and familial Parkinson's Disease. The company was founded on April 8, 1999 and is headquartered in Cherry Hill, NJ.

First Choice Healthcare Solutions stock logo

First Choice Healthcare Solutions OTCMKTS:FCHS

$0.0042 0.00 (0.00%)
As of 07/3/2025

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.

OpGen stock logo

OpGen NASDAQ:OPGN

$4.73 0.00 (0.00%)
As of 07/3/2025

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.